ADC Therapeutics' IFRS loss for 6 months of 2021 was $124.096 million, down 27% from $170.033 million in the prior year. Revenues were $3.76 million. A year earlier, the company did not generate revenues.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept